The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Fox Jonathan C | Director | Grant(A) | 319 | — | $0 |
| Jul 1, 2026 | Russell Alan J | Chief Scientific Officer, Director | Option exercise(M) | 130K | $0.45 | $59K |
| Jul 1, 2026 | Russell Alan J | Chief Scientific Officer, Director | Option exercise(M) | 70K | $0.18 | $13K |
| Jul 1, 2026 | Russell Alan J | Chief Scientific Officer, Director | Sell(S) | 130K | $39.41 | $5.1M |
| Jul 1, 2026 | Russell Alan J | Chief Scientific Officer, Director | Sell(S) | 70K | $39.41 | $2.7M |
| Jul 1, 2026 | Russell Alan J | Chief Scientific Officer, Director | Option exercise(M) | 130K | — | $0 |
| Jul 1, 2026 | Russell Alan J | Chief Scientific Officer, Director | Option exercise(M) | 70K | — | $0 |
| Jun 5, 2026 | Edris Badreddin | Director | Grant(A) | 6K | — | $0 |
| Jun 5, 2026 | Edris Badreddin | Director | Grant(A) | 8K | — | $0 |
| Jun 5, 2026 | Fox Jonathan C | Director | Grant(A) | 16K | — | $0 |
| Jun 5, 2026 | Martin Christopher Nathan | Director | Grant(A) | 16K | — | $0 |
| Jun 5, 2026 | Morris Arlene | Director | Grant(A) | 16K | — | $0 |
| Jun 5, 2026 | Thompson Peter A. | Director, 10% Owner | Grant(A) | 16K | — | $0 |
| Jun 5, 2026 | Brege Laura | Director | Grant(A) | 16K | — | $0 |
| May 5, 2026 | Donovan Joanne M. | CMO | Option exercise(M) | 50K | — | $0 |
| May 5, 2026 | Donovan Joanne M. | CMO | Sell(S) | 50K | $38.57 | $1.9M |
| May 5, 2026 | Donovan Joanne M. | CMO | Option exercise(M) | 50K | $7.08 | $354K |
| May 4, 2026 | Donovan Joanne M. | CMO | Sell(S) | 5K | $31.29 | $164K |
| Apr 1, 2026 | Fox Jonathan C | Director | Grant(A) | 339 | — | $0 |
| Apr 1, 2026 | Donovan Joanne M. | CMO | Option exercise(M) | 29K | — | $0 |
| Apr 1, 2026 | Donovan Joanne M. | CMO | Sell(S) | 29K | $32.31 | $926K |
| Apr 1, 2026 | Donovan Joanne M. | CMO | Option exercise(M) | 29K | $7.08 | $203K |
| Mar 31, 2026 | Donovan Joanne M. | CMO | Sell(S) | 21K | $32.12 | $685K |
| Mar 31, 2026 | Donovan Joanne M. | CMO | Option exercise(M) | 21K | $7.08 | $151K |
| Mar 31, 2026 | Donovan Joanne M. | CMO | Option exercise(M) | 21K | — | $0 |
| Mar 27, 2026 | Donovan Joanne M. | CMO | Sell(S) | 10K | $30.98 | $298K |
| Mar 27, 2026 | Donovan Joanne M. | CMO | Sell(S) | 7K | $30.98 | $209K |
| Jan 21, 2026 | Edris Badreddin | Director | Sell(S) | 14K | $29.44 | $403K |
| Jan 21, 2026 | Edris Badreddin | Director | Option exercise(M) | 8K | $0.71 | $5K |
| Jan 21, 2026 | Edris Badreddin | Director | Option exercise(M) | 10K | $1.93 | $20K |
| Jan 21, 2026 | Edris Badreddin | Director | Option exercise(M) | 17K | $0.64 | $11K |
| Jan 21, 2026 | Edris Badreddin | Director | Option exercise(M) | 14K | $0.39 | $5K |
| Jan 21, 2026 | Edris Badreddin | Director | Option exercise(M) | 66K | $1.93 | $128K |
| Jan 21, 2026 | Edris Badreddin | Director | Sell(S) | 66K | $29.44 | $2.0M |
| Jan 21, 2026 | Edris Badreddin | Director | Sell(S) | 10K | $29.44 | $308K |
| Jan 21, 2026 | Edris Badreddin | Director | Sell(S) | 17K | $29.44 | $507K |
| Jan 21, 2026 | Edris Badreddin | Director | Sell(S) | 8K | $29.44 | $224K |
| Jan 21, 2026 | Edris Badreddin | Director | Option exercise(M) | 66K | — | $0 |
| Jan 21, 2026 | Edris Badreddin | Director | Option exercise(M) | 14K | — | $0 |
| Jan 21, 2026 | Edris Badreddin | Director | Option exercise(M) | 17K | — | $0 |
| Jan 21, 2026 | Edris Badreddin | Director | Option exercise(M) | 8K | — | $0 |
| Jan 21, 2026 | Edris Badreddin | Director | Option exercise(M) | 10K | — | $0 |
| Jan 2, 2026 | Fox Jonathan C | Director | Grant(A) | 473 | — | $0 |
| Nov 19, 2025 | Martin Christopher Nathan | Director | Grant(A) | 45K | — | $0 |
| Nov 12, 2025 | Russell Alan J | Chief Scientific Officer, Director | Sell(S) | 100K | $21.12 | $2.1M |
| Nov 12, 2025 | Russell Alan J | Chief Scientific Officer, Director | Option exercise(M) | 100K | $0.18 | $18K |
| Nov 12, 2025 | Russell Alan J | Chief Scientific Officer, Director | Option exercise(M) | 100K | — | $0 |
| Nov 11, 2025 | Fox Jonathan C | Director | Buy(P) | 11K | $18.64 | $199K |
| Nov 10, 2025 | Nofi Michael | Chief Financial Officer | Grant(A) | 44K | — | $0 |
| Nov 10, 2025 | Nofi Michael | Chief Financial Officer | Grant(A) | 263K | — | $0 |
| Oct 1, 2025 | Fox Jonathan C | Director | Grant(A) | 728 | — | $0 |
| Aug 26, 2025 | Russell Alan J | Chief Scientific Officer, Director | Sell(S) | 100K | $14.60 | $1.5M |
| Aug 26, 2025 | Russell Alan J | Chief Scientific Officer, Director | Option exercise(M) | 100K | $0.18 | $18K |
| Aug 26, 2025 | Russell Alan J | Chief Scientific Officer, Director | Option exercise(M) | 100K | — | $0 |
| Aug 12, 2025 | Donovan Joanne M. | CMO | Sell(S) | 3K | $13.39 | $38K |
| Aug 12, 2025 | Donovan Joanne M. | CMO | Option exercise(M) | 6K | — | $0 |
| Aug 12, 2025 | Donovan Joanne M. | CMO | Grant(A) | 28K | — | $0 |
| Aug 12, 2025 | Donovan Joanne M. | CMO | Grant(A) | 169K | — | $0 |
| Aug 12, 2025 | Donovan Joanne M. | CMO | Option exercise(M) | 6K | — | $0 |
| Aug 12, 2025 | Koch Kevin | President and CEO, Director | Sell(S) | 8K | $13.39 | $107K |
| Aug 12, 2025 | Koch Kevin | President and CEO, Director | Option exercise(M) | 18K | — | $0 |
| Aug 12, 2025 | Koch Kevin | President and CEO, Director | Grant(A) | 525K | — | $0 |
| Aug 12, 2025 | Koch Kevin | President and CEO, Director | Grant(A) | 88K | — | $0 |
| Aug 12, 2025 | Koch Kevin | President and CEO, Director | Option exercise(M) | 18K | — | $0 |
| Aug 12, 2025 | Russell Alan J | Chief Scientific Officer, Director | Sell(S) | 2K | $13.39 | $26K |
| Aug 12, 2025 | Russell Alan J | Chief Scientific Officer, Director | Option exercise(M) | 6K | — | $0 |
| Aug 12, 2025 | Russell Alan J | Chief Scientific Officer, Director | Grant(A) | 169K | — | $0 |
| Aug 12, 2025 | Russell Alan J | Chief Scientific Officer, Director | Option exercise(M) | 6K | — | $0 |
| Aug 12, 2025 | Russell Alan J | Chief Scientific Officer, Director | Grant(A) | 28K | — | $0 |
| Aug 12, 2025 | Carruthers R Michael | Chief Financial Officer | Option exercise(M) | 6K | — | $0 |
| Aug 12, 2025 | Carruthers R Michael | Chief Financial Officer | Sell(S) | 1K | $13.39 | $19K |
| Aug 12, 2025 | Carruthers R Michael | Chief Financial Officer | Grant(A) | 27K | — | $0 |
| Aug 12, 2025 | Carruthers R Michael | Chief Financial Officer | Option exercise(M) | 6K | — | $0 |
| Aug 12, 2025 | Carruthers R Michael | Chief Financial Officer | Grant(A) | 161K | — | $0 |
| Aug 12, 2025 | Derakhshan Behrad | Chief Business Officer | Sell(S) | 2K | $13.39 | $33K |
| Aug 12, 2025 | Derakhshan Behrad | Chief Business Officer | Option exercise(M) | 6K | — | $0 |
| Aug 12, 2025 | Derakhshan Behrad | Chief Business Officer | Grant(A) | 180K | — | $0 |
| Aug 12, 2025 | Derakhshan Behrad | Chief Business Officer | Grant(A) | 30K | — | $0 |
| Aug 12, 2025 | Derakhshan Behrad | Chief Business Officer | Option exercise(M) | 6K | — | $0 |
| Aug 12, 2025 | Moore John R | General Counsel | Sell(S) | 2K | $13.39 | $28K |
| Aug 12, 2025 | Moore John R | General Counsel | Option exercise(M) | 6K | — | $0 |
| Aug 12, 2025 | Moore John R | General Counsel | Grant(A) | 27K | — | $0 |
| Aug 12, 2025 | Moore John R | General Counsel | Grant(A) | 161K | — | $0 |
| Aug 12, 2025 | Moore John R | General Counsel | Option exercise(M) | 6K | — | $0 |
| Aug 12, 2025 | Blaustein Robert | Chief Development Officer | Grant(A) | 105K | — | $0 |
| Aug 12, 2025 | Blaustein Robert | Chief Development Officer | Grant(A) | 18K | — | $0 |
| Jul 1, 2025 | Fox Jonathan C | Director | Grant(A) | 858 | — | $0 |
| Jun 16, 2025 | Thompson Peter A. | Director, 10% Owner | Grant(A) | 30K | — | $0 |
| Jun 16, 2025 | Root Jonathan D | Director | Grant(A) | 30K | — | $0 |
| Jun 16, 2025 | Morris Arlene | Director | Grant(A) | 30K | — | $0 |
| Jun 16, 2025 | Fox Jonathan C | Director | Grant(A) | 30K | — | $0 |
| Jun 16, 2025 | Edris Badreddin | Director | Grant(A) | 30K | — | $0 |
| Jun 16, 2025 | Brege Laura | Director | Grant(A) | 30K | — | $0 |
| May 2, 2025 | Carruthers R Michael | Chief Financial Officer | Sell(S) | 1K | $16.45 | $22K |
| May 2, 2025 | Derakhshan Behrad | Chief Business Officer | Sell(S) | 2K | $16.45 | $28K |
| May 2, 2025 | Donovan Joanne M. | CMO | Sell(S) | 5K | $16.45 | $85K |
| May 2, 2025 | Koch Kevin | President and CEO, Director | Sell(S) | 4K | $16.45 | $70K |
| May 2, 2025 | Moore John R | General Counsel | Sell(S) | 2K | $16.45 | $32K |
| May 2, 2025 | Russell Alan J | Chief Scientific Officer, Director | Sell(S) | 2K | $16.45 | $26K |
| May 1, 2025 | Carruthers R Michael | Chief Financial Officer | Option exercise(M) | 5K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).